INTERPACE BIOSCIENCES, INC. (IDXG) › Operating Cash FlowINTERPACE BIOSCIENCES, INC. (IDXG) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: $16.35M2011: $1.99M2012: -$10.29M2013: -$3.51M2014: -$16.38M2015: -$19.84M2016: -$7.61M2017: -$15.26M2018: -$8.67M2019: -$18.96M2020: -$13.98M2021: -$8.72M2022: -$7.69M2023: $3.79M2024: $4.65M2025: $5.83M$5.83M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025$5.83M+25.5%2024$4.65M+22.6%2023$3.79M+149.3%2022-$7.69M+11.8%2021-$8.72M+37.6%2020-$13.98M+26.3%2019-$18.96M-118.6%2018-$8.67M+43.2%2017-$15.26M-100.6%2016-$7.61M+61.7%2015-$19.84M-21.2%2014-$16.38M-366.3%2013-$3.51M+65.9%2012-$10.29M-618.2%2011$1.99M-87.9%2010$16.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share